Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Technologies For Improving Minority Health and Eliminating Health ...
open51 vistasUSA

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

A funding opportunity from the National Institutes of Health for research on schizophrenia and related disorders in mid- to late-life. Supports R21 clinical trials with case-dependent funding.

Quién puede solicitar

Applicants must follow the Research (R) Instructions in the How to Apply - Application Guide. The opportunity is open to those proposing high risk/high reward projects that lack preliminary data.

Similar grants

Other open funding opportunities that may be a good fit.